Aethlon Medical (NASDAQ:AEMD) Earns “Buy” Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Aethlon Medical (NASDAQ:AEMD) in a research note published on Friday,Benzinga reports. They currently have a $7.00 target price on the medical equipment provider’s stock.

Separately, StockNews.com assumed coverage on Aethlon Medical in a research report on Friday, November 8th. They set a “sell” rating on the stock.

Aethlon Medical Stock Up 0.2 %

Shares of AEMD stock opened at $0.40 on Friday. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $2.35. The business’s fifty day simple moving average is $0.40 and its 200-day simple moving average is $0.48.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.